Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are biologically female
- People who have been diagnosed with stage I, II, or III breast cancer
- People who were post-menopausal at the time of their breast cancer diagnosis, meaning their last menstrual period was at least 12 months before diagnosis
- People who have taken a type of hormone-blocking medication called aromatase inhibitors for 12 months or more in the past (not necessarily currently)
- People with a body mass index (BMI) of 25 or higher (confirm with trial site if unsure of your BMI)
- People who are willing and able to complete all study activities
- People who are able to travel to the University once per week for 24 weeks
Who may not be able to join:
- People who have received chemotherapy in the past 11 months
- People who have been diagnosed with cancer that has spread to other parts of the body (metastatic cancer), including if this happened after an early-stage breast cancer diagnosis
- People who are currently taking a hormone-blocking medication called tamoxifen
- People who are currently receiving chemotherapy, targeted cancer therapy, or radiation treatment
- People who have been diagnosed with heart disease, type 2 diabetes, non-alcoholic fatty liver disease, an uncontrolled thyroid condition, or a breathing condition such as severe asthma or COPD
- People who have significant symptoms that may suggest heart, diabetes, or kidney problems — such as chest pain, shortness of breath at rest or with light activity, dizziness or fainting, swollen ankles, irregular heartbeat, unusual leg pain when walking, a known heart murmur, or unusual tiredness with everyday activities
- People with certain serious heart or cardiovascular conditions that make supervised maximum-effort exercise testing unsafe, such as a recent heart attack, heart failure, blood clots in the lungs, heart inflammation, uncontrolled irregular heartbeat, stroke, very high blood pressure (above 200/100 mmHg), or a cancer diagnosis other than skin cancer (confirm with trial site for full list)
- People who are unable to give informed consent or communicate in English
- People who are currently pregnant or breastfeeding, or have been in the past 3 months
- People who have mobility limitations that affect their ability to do aerobic exercise, such as using a wheelchair, walker, or having a limp that affects walking
- People who have smoked cigarettes or marijuana in the past 3 months
- People who are currently taking or have taken hormone medications of any kind in the past 3 months
- People who cannot have a research MRI scan, for example due to a pacemaker or certain metal implants
- People with a BMI over 40
- People with severe claustrophobia (fear of enclosed spaces)
- People who are already doing more than 30 minutes per week of moderate-to-vigorous aerobic exercise
- People who have been following a diet that heavily restricts entire food groups or eating times in the past 3 months (such as vegan, ketogenic, carnivore, or one-meal-a-day diets)
- People who have lost more than 5 kg in weight in the past 3 months
- People who are currently taking weight loss medications
- People who have a diagnosed eating disorder, or who suspect they may have an undiagnosed eating disorder
- People who plan to be unavailable for more than 4 weeks total across the 6-month program, or more than 2 weeks during the first 12 weeks
- People who have an allergy to local anaesthetics
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amy A Kirkham, PhD, University of Toronto
Phone: 416-946-4069
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin resistance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.